These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 21143620

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
    Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD, Dong YG.
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of metformin on primary cardiomyocytes via activation of adenosine monophosphate-activated protein kinase.
    Wang XF, Zhang JY, Li L, Zhao XY.
    Chin Med J (Engl); 2011 Jun; 124(12):1876-84. PubMed ID: 21740847
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure.
    Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D, Ramachandran A, Anaya-Cisneros M, Tian R, Lefer DJ.
    Circ Res; 2009 Feb 13; 104(3):403-11. PubMed ID: 19096023
    [Abstract] [Full Text] [Related]

  • 6. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.
    Coyral-Castel S, Tosca L, Ferreira G, Jeanpierre E, Rame C, Lomet D, Caraty A, Monget P, Chabrolle C, Dupont J.
    J Neuroendocrinol; 2008 Mar 13; 20(3):335-46. PubMed ID: 18194429
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo.
    Shearer J, Fueger PT, Rottman JN, Bracy DP, Martin PH, Wasserman DH.
    Am J Physiol Endocrinol Metab; 2004 Nov 13; 287(5):E871-7. PubMed ID: 15265760
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
    Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M.
    Circulation; 2009 May 19; 119(19):2568-77. PubMed ID: 19414638
    [Abstract] [Full Text] [Related]

  • 12. Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration.
    Solskov L, Løfgren B, Kristiansen SB, Jessen N, Pold R, Nielsen TT, Bøtker HE, Schmitz O, Lund S.
    Basic Clin Pharmacol Toxicol; 2008 Jul 19; 103(1):82-7. PubMed ID: 18484962
    [Abstract] [Full Text] [Related]

  • 13. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
    Horinaka S, Kobayashi N, Yagi H, Mori Y, Matsuoka H.
    J Cardiovasc Pharmacol; 2006 May 19; 47(5):629-35. PubMed ID: 16775500
    [Abstract] [Full Text] [Related]

  • 14. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT, Li WM, Xiu CH, Shen JX, Wang X, Wu S, Kong YH.
    Chin Med J (Engl); 2007 Dec 20; 120(24):2250-5. PubMed ID: 18167212
    [Abstract] [Full Text] [Related]

  • 15. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
    Huypens P, Quartier E, Pipeleers D, Van de Casteele M.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):90-5. PubMed ID: 16039647
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y, Ohmori K, Chen Y, Sato C, Kiyomoto H, Shinomiya K, Takeuchi H, Mizushige K, Kohno M.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):904-13. PubMed ID: 15312879
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS, Agata J, Xia CF, Chao L, Chao J.
    Life Sci; 2005 Apr 08; 76(21):2457-71. PubMed ID: 15763077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.